Drug Delivery Market- Oral, Pulmonary, Injectable, Novel, Ocular, Nasal, Topical, Implantable & Transmucosal Technologies Analyzed in Research Reports at ReportsnReports
“Drug Delivery Technologies Market” research reports available for Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants, Novel Product and Formulation Technology at ReportsnReports.com store.
Dallas, Texas (PRWEB) July 25, 2013
The North American drug delivery market was estimated to be worth $66.7 billion in 2012, and is expected to register a CAGR of 8.9% between 2012 and 2017. Based on the route of administration, the drug delivery market has been classified as oral, pulmonary, injectable, transdermal, implantable, ocular, nasal, transmucosal, and topical. In 2012, oral drug delivery segment dominated the market with a share of approximately 38%, followed by pulmonary drug delivery segment with a 20% share.
The North American drug delivery (http://www.reportsnreports.com/reports/264729-north-american-drug-delivery-technologies-market-metered-dose-inhalers-needle-free-injectors-auto-injectors-nasal-sprays-transdermal-patches-nebulizers-infusion-pumps-drug-eluting-stents-sustained-release-ocular-implants-forecasts-to-2017.html) market is largely dominated by the U.S. (accounting for about 89% of the overall market). The key drivers for the U.S. drug delivery market are the well established pharmaceutical industry , healthcare reforms, and favourable changes in the FDA review process. Factors such as low cost drug manufacturing and rising number of drug delivery formulations and devices are propelling the Canadian market.
Key players in the drug delivery technologies market for North American are 3M Company (U.S.), Aptalis Pharma, Inc. (U.S.), Baxter International, Inc. (U.S.), Becton, Dickinson & Co. (U.S.), Catalent Pharma Solutions (U.S.), The Dow Chemical Company (U.S.), Endo Pharmaceuticals (U.S.), Johnson & Johnson (U.S.), Nektar Therapeutics (U.S.) and Valeant Pharmaceuticals (Canada).
Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=264729.
European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) – Forecasts to 2017 (http://www.reportsnreports.com/reports/254221-european-drug-delivery-technologies-market-metered-dose-inhalers-needle-free-injectors-auto-injectors-nasal-sprays-transdermal-patches-nebulizers-infusion-pumps-drug-eluting-stents-sustained-release-ocular-implants-forecasts-to-2017.html) –
The European drug delivery market was worth $39.9 billion in the year 2012. The drug delivery technology market is segmented on the basis of route of administration into nine categories – oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery. Over the years, drug delivery technologies have grown phenomenally from plain drug reformulation and release technologies, to innovative platforms that hold a huge potential for the effective delivery of biologicals and novel drugs.
Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=254221.
Drug delivery market, by technologies
- Controlled Release
- Orodispersible Tablets (ODT) and Taste Masking
- Dry Powder Inhalers
- Metered Dose Inhalers
- Reservoir System
- Matrix System
Conventional Injection Devices
- Fillable Syringes
- Prefilled Syringes
- Needle-free Injectors
- Auto-injectors or Safety Syringe Devices
- Pen Injectors
- Eye Drops
- Ointment and Gel
- Nasal Drops
- Nasal Sprays
- Nasal Inhalers
- Liquid Formulations
- Semi-solid Formulations
- Solid Formulations
- Drug Eluting Stents
- Implantable Infusion Pumps
- Intravitreal Implants
- Brachytherapy Seeds
- Contraceptive Implants
- Oral (Buccal and Sublingual)
- Others (Rectal and Vaginal)
Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies http://www.reportsnreports.com/reports/254091-innovative-drug-delivery-systems-novel-product-and-formulation-technology-licensing-opportunities-for-generic-pharmaceutical-companies.html
Global injectable drug delivery market is expected to be worth $29 billion by 2015. The oral drug delivery market remains the largest slice of the overall drug delivery market, with more than 52% of market share. It is presently valued at $49 billion and is expected to reach over $90 billion by 2016, at a CAGR of 11%. The growth in the oral drug delivery market shall be driven primarily by newer technologies enabling controlled release formulations of oral drugs and oral formulations of injectable only drugs.
Novel drug delivery systems (NDDS) offer many more advantages, which include improved therapy by increasing the efficacy and duration of drug activity, increased patient compliance through decreased dosing frequency and convenient routes of administration, and improved targeting for a specific site to reduce unwanted side effects. The challenge for both drug and drug delivery companies is to deliver both existing and emerging drug technologies in a manner that improves the current benefits enjoyed by the patients.
Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=254091.
Global Pulmonary Drug Delivery Systems Market 2012-2016 – http://www.reportsnreports.com/reports/266323-global-pulmonary-drug-delivery-systems-market-2012-2016.html
Analysts forecast the Global Pulmonary Drug Delivery Systems market to grow at a CAGR of 14.47 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing incidence of lung-related or respiratory diseases. The Global Pulmonary Drug Delivery Systems market has also been witnessing an increasing adoption of online marketing strategy. However, intense competition among vendors could pose a challenge to the growth of this market.
The other vendors mentioned in this report are Akela Pharma Inc., Alkermes Inc., Allied Healthcare Products Inc., Boehringer Ingelheim GmbH, CareFusion Corp., Chiesi Farmaceutici S.p.A., Dainippon Sumitomo Pharma Co. Ltd., GF Health Products Inc., Novartis AG, PARI Respiratory Equipment Inc., Philips Respironics Inc., Omron Healthcare Co. Ltd., and more.
Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=266323.
ReportsnReports.com is an online market research reports library of 200,000+ reports and in-depth studies of 5000+ micro markets. Our database includes reports by leading publishers from across the globe.
For the original version on PRWeb visit: http://www.prweb.com/releases/drug-delivery-market-oral/pulmonary-injectable/prweb10963981.htm